Skip to main content
JADPRO Live 2024 Main banner
Icon Legend
ICONS KEY
CE Credit Available
CE Credit Available
Pharmacology Credit Available
Pharmacology Credit Available
Poster Activities
Poster Activities

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Saturday, November 16, 2024
  • 7:00 AM – 8:15 AM CT
    Breakfast Activity/Non-CE Accredited Satellite Symposium: A Treatment Option for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma
    Merck
  • 7:00 AM – 8:15 AM CT
    Breakfast Activity/Non-CE Accredited Satellite Symposium: An Outpatient Treatment Option for Patients with 3L+ Follicular Lymphoma, A Fixed-Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma
    Genentech
  • 7:00 AM – 8:15 AM CT
    Breakfast Activity/Non-CE Accredited Satellite Symposium: Treatment Options for Patients with Metastatic Non-Small Cell Lung Cancer​
    Bristol Myers Squibb
  • 7:00 AM – 8:15 AM CT
    Breakfast Activity/Non-CE Accredited Satellite Symposium: Understanding AYVAKIT for Indolent Systemic Mastocytosis (ISM)
    Blueprint/Red Nucleus
  • 7:00 AM – 8:15 AM CT
    Exhibit Hall Open & Continental Breakfast
  • 7:00 AM – 5:30 PM CT
    Registration
  • 8:20 AM – 8:30 AM CT
    Opening Remarks & APSHO FAPO Recognition Presentation
  • 8:30 AM – 8:40 AM CT
    The Annual Mary Pazdur Award Presentation
  • 8:45 AM – 9:15 AM CT
    The Mary Pazdur Award Recipient Lecture
  • 9:20 AM – 10:20 AM CT
    Diagnostic Imaging in Surgical Oncology
  • 9:20 AM – 10:20 AM CT
    Harnessing the Power of Predictive Biomarkers in Precision Oncology
  • 9:20 AM – 10:20 AM CT
    Managing Dermatologic Side Effects in Patients With Cancer
  • 9:45 AM – 4:30 PM CT
    Braindate
  • 10:25 AM – 10:55 AM CT
    APSHO Meet & Greet: Radiation Oncology
  • 10:25 AM – 11:25 AM CT
    Exhibit Hall Open & Refreshment Break
  • 10:25 AM – 11:25 AM CT
    Moderated Posters: Clinical Posters, Industry Encore Posters, and APSHO Patient Advocacy Posters
  • 10:35 AM – 11:05 AM CT
    Exhibit Hall Presentation Theater: HER2 Expression Informs Clinical Decision Making in HER2-Low mBC
    Daiichi Sankyo, Inc. and AstraZeneca
  • 10:35 AM – 11:05 AM CT
    Exhibit Hall Presentation Theater: Understanding the role of pharmacists in the management of Low-risk Myelodysplastic Syndromes (MDS)
    Bristol Myers Squibb
  • 10:35 AM – 11:20 AM CT
    Exhibit Hall Presentation Theater: Diving Deep into Venetoclax Fixed Treatment Duration Regimens and Time Off Treatment
    AbbVie
  • 10:55 AM – 11:25 AM CT
    APSHO Meet & Greet: Research Quality & Improvement (RQI) Committee
  • 11:30 AM – 12:30 PM CT
    Addressing Cancer Survivorship in Vulnerable Populations
  • 11:30 AM – 12:30 PM CT
    Advancing Care for Patients with Resectable NSCLC
  • 11:30 AM – 12:30 PM CT
    Fast Tracking Recovery: Enhancing Surgical Outcomes in Oncology
  • 12:30 PM – 1:45 PM CT
    Exhibit Hall Open & Lunch
  • 12:30 PM – 1:45 PM CT
    Lunch Activity/Non-CE Accredited Satellite Symposium: A First-Line Treatment Option for Adults with Symptomatic Anemia Due To Lower-Risk MDS
    Bristol Myers Squibb
  • 12:30 PM – 1:45 PM CT
    Lunch Activity/Non-CE Accredited Satellite Symposium: The Facts on the Combined Power of RYBREVANT® + LAZCLUZE for the First-Line Treatment of EGFR+ Locally Advanced or mNSCLC
    Johnson & Johnson
  • 12:30 PM – 1:45 PM CT
    Lunch Activity/Non-CE Accredited Satellite Symposium: Treatment of Adults With Certain BRAF–Mutated Metastatic Melanoma, Colorectal, and Non-Small Cell Lung Cancers
    Pfizer, Inc.
  • 12:30 PM – 2:00 PM CT
    Lunch Activity/Non-CE Accredited Satellite Symposium: A Coordinated Care Team Approach to the Management of Patients Taking Jakafi for Chronic Graft-Versus-Host Disease
    Incyte Corporation
  • 1:15 PM – 1:45 PM CT
    APSHO Meet & Greet: Education Committee
  • 1:45 PM – 2:15 PM CT
    Providing Culturally Inclusive Care in the Surgical Oncology Setting
  • 1:45 PM – 2:45 PM CT
    Fundamentals of Radiation Oncology: What the Advanced Practitioner Needs to Know
  • 1:45 PM – 2:45 PM CT
    New Drug Updates: Investigational Therapeutics in the Pipeline
  • 2:15 PM – 2:45 PM CT
    Principles of Wound Care in the Surgical Oncology Setting
  • 2:45 PM – 4:00 PM CT
    Exhibit Hall Open & Refreshment Break
  • 3:00 PM – 3:30 PM CT
    APSHO Meet & Greet: Professional Development & Leadership (PD&L) Committee
  • 3:00 PM – 3:30 PM CT
    Exhibit Hall Presentation Theater: Rethink Thalassemia: A Deep Dive Into Its Pathophysiology, Risks, and Complications.
    Agios
  • 3:00 PM – 3:45 PM CT
    Exhibit Hall Presentation Theater: A STEP FORWARD - Initiating VENCLEXTA Treatment in Patients with CLL
    AbbVie
  • 3:00 PM – 3:45 PM CT
    Exhibit Hall Presentation Theater: Redefining Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma: A Focus on the Outcomes of Transplant-Eligible and Transplant-Ineligible Patients as seen in the PERSEUS and MAIA Trials
    Johnson & Johnson
  • 3:45 PM – 5:00 PM CT
    New-to-Oncology Roundtables
  • 4:00 PM – 5:00 PM CT
    Evidence-Based Strategies for Well-Being and Professional Fulfillment
  • 4:00 PM – 5:00 PM CT
    Optimizing the Care of Patients With Higher-Risk Myelofibrosis
  • 5:00 PM – 6:30 PM CT

    Independent CE-Accredited Satellite Symposium

    Novel Therapeutics and Essential Strategies for Optimized Outcomes in Relapsed/Refractory Multiple Myeloma
  • 5:45 PM – 6:30 PM CT

    Independent CE-Accredited Satellite Symposium

    Updates and Evidence-Based Strategies in Non-Small Cell Lung Cancer: A Focus on Molecular Testing, Targeted Treatment, and Adverse Event Management
  • 6:30 PM – 8:30 PM CT

    Independent CE-Accredited Satellite Dinner Symposium

    The Amazing Case: Charting the Course of Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Relapsed/Refractory Follicular Lymphoma with Bispecific Antibodies